527
Views
5
CrossRef citations to date
0
Altmetric
Respiratory

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand

&
Pages 955-961 | Received 03 Nov 2016, Accepted 17 Feb 2017, Published online: 21 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mau Ern Poh, Soon Hin How, Gwo Fuang Ho, Yong Kek Pang, Harissa H Hasbullah, Lye Mun Tho, Ibtisam Muhamad Nor, Bee Chiu Lim, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Sing Yang Soon, Justin Yu Kuan Tan & Muhammad Adil Zainal Abidin. (2023) Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country. Cancer Management and Research 15, pages 31-41.
Read now

Articles from other publishers (4)

Alyssa Grant, Chia Jie Tan, Somkiat Wattanasirichaigoon, Suthat Rungruanghiranya, Araya Thongphiew, Kednapa Thavorn & Nathorn Chaiyakunapruk. (2023) Cost-effectiveness analysis of the SMART quit clinic program in smokers with cardiovascular disease in Thailand. Tobacco Induced Diseases 21:April, pages 1-9.
Crossref
Lu Han, Xin Zhang, Wen-Qi Fu, Cheng-Yao Sun, Xian-Ming Zhao, Liang-Ru Zhou & Guo-Xiang Liu. (2020) A systematic review of the budget impact analyses for antitumor drugs of lung cancer. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Unchalee Permsuwan, Sumitra Thongprasert & Buntitabhon Sirichanchuen. (2020) Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand. Value in Health Regional Issues 21, pages 9-16.
Crossref
Apinut Rankantha, Imjai Chitapanarux, Donsuk Pongnikorn, Sukon Prasitwattanaseree, Walaithip Bunyatisai, Patumrat Sripan & Patrinee Traisathit. (2018) Risk patterns of lung cancer mortality in northern Thailand. BMC Public Health 18:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.